by Nazanin Arjomand Fard, MSci; Gholamreza Azizi, PhD; and Abbas Mirshafiey, PhD Dr. Fard is with Kish International Campus, University of Tehran, Tehran, Iran; Dr. Azizi is with Imam Hassan
by Ram S. Mahato, MD; Maria Chona P. San Gabriel, MD; Carrol T. Longshore, MD; and David B. Schnur, MD The authors are with the Department of Psychiatry at Elmhurst
by Donna Vanderpool, MBA, JD Ms. Vanderpool is Vice President of Risk Management at PRMS, Inc., Arlington, Virginia. Innov Clin Neurosci. 2016;13(7–8):41–44. This ongoing column is dedicated to providing information
Innov Clin Neurosci. 2016;13(7–8):15–16. Dear Editor: Borderline personality disorder (BPD) is over-represented in prison populations, with 25 to 50 percent of incarcerated individuals suffering from this disorder.[1] As an empirical
Innov Clin Neurosci. 2016;13(7–8):13–14. Dear Editor: Substance use disorders frequently coexist with and complicate the treatment of mood and anxiety disorders. Gabapentin is one of the most commonly prescribed off-label
The latest in neuroscience—sorted and summarized for you Welcome to The Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to
The latest in neuroscience—sorted and summarized for you Welcome to The Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to
The latest in neuroscience—sorted and summarized for you Welcome to The Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to
by Arshya Vahabzadeh, MD; Ned Sahin, PhD; and Amir Kalali, MD Dr. Vahabzadeh is Director of Digital Health, Brain Power, in Cambridge, Massachusetts; Instructor in Psychiatry, Harvard Medical School in
by Kimberly B. Mulcahy, PharmD; Eileen Trigoboff, RN, DNS; Lewis Opler, MD, PhD; and Tammie Lee Demler, BS, PharmD, MBA Drs. Trigoboff, Demler, and Mulcahy are with Buffalo Psychiatric Center,
by Masaru Nakamura, MD, PhD; Takahiko Nagamine, MD, PhD; Goro Sato, MD, PhD; and Kazue Besho, Phc Dr. Nakamura is with the Department of Psychiatric Internal Medicine, Kosekai-Kusatsu Hospital, Hiroshima,
by Ahmed Aboraya, MD, DrPh; Henry Nasrallah, MD; Srinivas Muvvala, MD, MPH; Ahmed El-Missiry, MD, MRCPsych, IFAPA; Hader Mansour, MD, PhD; Cheryl Hill, MD PhD; Daniel Elswick, MD; and Elizabeth
by Hena Jawaid, MB, BS, FCPS; Sana Younus, MB, BS; and Hanif Mesiya, MD All are with the Department of Psychiatry, Aga Khan University, Karachi, Pakistan. Innov Clin Neurosci. 2016;13(5–6):78–80.
by Ann McNary, JD Ms. McNary is a Senior Risk Manager with PRMS, Inc. Innov Clin Neurosci. 2016;13(5–6):81–82. This ongoing column is dedicated to providing information to our readers on
Innov Clin Neurosci. 2016;13(5–6):13–14 Dear Editor: Brown and Rais[1] offer an interesting case report of the autistic son of a mother with a “multisystem litany of symptoms and diseases… typical
Dear Editor: Polydipsia can lead to episodic life-threatening water intoxication and is a serious problem in many patients with chronic schizophrenia.[1] Although multiple factors have been implicated,[2] the reason why
The latest in neuroscience—sorted and summarized for you Welcome to The Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to
The latest in neuroscience—sorted and summarized for you Welcome to The Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to
The latest in neuroscience—sorted and summarized for you Welcome to The Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to
